Reversal effect of recombinant human Endostatin on cisplatin resistance in A549/DDP human lung adenocarcinoma cells in vitro

By Che Yuxuan   Xu Jiawei   Su Shuang   Sun Xiuhua   Li Man   Zhang Yang  

The Chinese-German Journal of Clinical Oncology, Vol. 12, Iss. 11, 2013-11 ,pp. : 509-515

Springer Publishing Company

Access to resources Recommend Favorite

In vivo antitumour efficacy of MGI-114 (6-hydroxymethylacylfulvene, HMAF) in various human tumour xenograft models including several lung and gastric tumours

By Sato Y.   Kashimoto S.   MacDonald J.R.   Nakano K.  

European Journal of Cancer, Vol. 37, Iss. 11, 2001-07 ,pp. : 1419-1428

Elsevier

Access to resources Recommend Favorite

Effect and mechanism of Src tyrosine kinase inhibitor sunitinib on the drug-resistance reversal of human A549/DDP cisplatin-resistant lung cancer cell line

By      

Molecular Medicine Reports, Vol. 10, Iss. 4, 2014-01 ,pp. : 2065-2072

Spandidos Publications

Access to resources Recommend Favorite

Enhanced antitumour activity of 6-hydroxymethylacylfulvene in combination with topotecan or paclitaxel in the MV522 lung carcinoma xenograft model

By Hammond L.A.   Hilsenbeck S.G.   Eckhardt S.G.   Marty J.   Mangold G.   MacDonald J.R.   Rowinsky E.K.   Von Hoff D.D.   Weitman S.  

European Journal of Cancer, Vol. 36, Iss. 18, 2000-12 ,pp. : 2430-2436

Elsevier

Access to resources Recommend Favorite

Effects of VBMDMP on the reversal of cisplatin resistance in human lung cancer A549/DDP cells

By  

Oncology Reports, Vol. 33, Iss. 1, 2015-01 ,pp. : 372-382

Spandidos Publications

Access to resources Recommend Favorite